Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.

Eur Thyroid J · 2026 · PMC13292826 · PMID 42258399

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The log-rank test showed a trend toward improved survival with matched therapy, although not statistically significant ( P = 0.058).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.